Get started
Author

Giuseppina Rosaria Rita Ricciardi

Observed names: G. R. R. Ricciardi, G. R. Ricciardi, G. Ricciardi, G.R. Ricciardi, G.R.R. Ricciardi, Giuseppina R Ricciardi, Giuseppina R. R. Ricciardi, Giuseppina R. Ricciardi, Giuseppina R.R. Ricciardi, Giuseppina RR Ricciardi, Giuseppina Ricciardi, Giuseppina Rosaria Ricciardi, Ricciardi, Giuseppina RR, Ricciardi, Giuseppina Rosaria Rita
ORCID: 0000-0002-7282-3597
Observed ORCID: 0000-0002-7282-3597
OpenAlex ID: A5107425833
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
2015 · Alessandro Russo, Tindara Franchina, et al. · Oncotarget · 177
PDF
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
2020 · Alessandro Russo, Marco Russano, et al. · Advances in Therapy · 176
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer: miRNAs expression and Pemetrexed response
2013 · Tindara Franchina, Valeria Amodeo, et al. · Journal of Cellular Physiology · 122
Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario
2019 · Alessandro Russo, Tindara Franchina, et al. · International Journal of Molecular Sciences · 116
PDF
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going
2017 · A. Russo, T. Franchina, et al. · Critical Reviews in Oncology/Hematology · 114
Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
2018 · Alessandro Russo, Tindara Franchina, et al. · Journal of Cellular Physiology · 104
PDF
NSCLC and HER2: Between Lights and Shadows
2014 · Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, et al. · Journal of Thoracic Oncology · 79
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
2015 · Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, et al. · PLoS ONE · 77
PDF
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
2020 · Alessandro Russo, Ana Rita Lopes, et al. · Current Oncology Reports · 65
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes
2023 · Mariausilia Franchina, Cristina Pizzimenti, et al. · International Journal of Molecular Sciences · 62
PDF
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review
2018 · Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, et al. · BMC Cancer · 50
PDF
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
2017 · Barbara Adamo, Giuseppina Rosaria Rita Ricciardi, et al. · Oncotarget · 50
PDF
Clinical significance of circulating interleukin‐23 as a prognostic factor in breast cancer patients
2012 · Sebastiano Gangemi, Paola Minciullo, et al. · Journal of Cellular Biochemistry · 42
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population
2013 · Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, et al. · Oncology · 33
PDF
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence
2020 · Eriseld Krasniqi, Laura Pizzuti, et al. · Journal of Cellular Physiology · 31
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
2023 · Irma Bisceglia, Maria Laura Canale, et al. · Frontiers in Cardiovascular Medicine · 24
PDF
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance
2016 · Alessandro Russo, Tindara Franchina, et al. · Expert Review of Anticancer Therapy · 23
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy
2018 · A. Russo, T. Franchina, et al. · Critical Reviews in Oncology/Hematology · 20
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases
2015 · Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, et al. · OncoTargets and Therapy · 19
PDF
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports
2012 · Tindara Franchina, Barbara Adamo, et al. · Cancer Biology & Therapy · 19
PDF
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience
2011 · V. Adamo, G.R.R. Ricciardi, et al. · European Journal of Cancer · 18
LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)
2024 · R.F. Salgado, A. Bardia, et al. · Annals of Oncology · 17
PDF
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
2023 · Nicoletta Colombo, Angiolo Gadducci, et al. · Gynecologic Oncology · 17
Ribociclib efficacy in special populations and analysis of patient-reported outcomes in the MONALEESA trials
2022 · Maria V. Sanò, Federica Martorana, et al. · Expert Review of Anticancer Therapy · 16
Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
2015 · Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, et al. · PLoS ONE · 15
PDF
Works count: 91
Citation count: 1,634
H-index: 19
I10-index: 30
Year
Topic
Type